These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
960 related items for PubMed ID: 22887810
21. Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance". Ohori NP, Nikiforova MN, Schoedel KE, LeBeau SO, Hodak SP, Seethala RR, Carty SE, Ogilvie JB, Yip L, Nikiforov YE. Cancer Cytopathol; 2010 Feb 25; 118(1):17-23. PubMed ID: 20099311 [Abstract] [Full Text] [Related]
23. BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid. Jin L, Sebo TJ, Nakamura N, Qian X, Oliveira A, Majerus JA, Johnson MR, Lloyd RV. Diagn Mol Pathol; 2006 Sep 25; 15(3):136-43. PubMed ID: 16932068 [Abstract] [Full Text] [Related]
24. Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. Sapio MR, Posca D, Raggioli A, Guerra A, Marotta V, Deandrea M, Motta M, Limone PP, Troncone G, Caleo A, Rossi G, Fenzi G, Vitale M. Clin Endocrinol (Oxf); 2007 May 25; 66(5):678-83. PubMed ID: 17381488 [Abstract] [Full Text] [Related]
25. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma. Costa AM, Herrero A, Fresno MF, Heymann J, Alvarez JA, Cameselle-Teijeiro J, García-Rostán G. Clin Endocrinol (Oxf); 2008 Apr 25; 68(4):618-34. PubMed ID: 18070147 [Abstract] [Full Text] [Related]
33. Cytological features and nuclear scores: Diagnostic tools in preoperative fine needle aspiration of indeterminate thyroid nodules with RAS or BRAF K601E mutations? Ravella L, Lopez J, Descotes F, Giai J, Lapras V, Denier ML, Borson-Chazot F, Lifante JC, Decaussin-Petrucci M. Cytopathology; 2021 Jan 25; 32(1):37-44. PubMed ID: 32803788 [Abstract] [Full Text] [Related]
34. BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features. Proietti A, Giannini R, Ugolini C, Miccoli M, Fontanini G, Di Coscio G, Romani R, Berti P, Miccoli P, Basolo F. Thyroid; 2010 Nov 25; 20(11):1263-70. PubMed ID: 20950194 [Abstract] [Full Text] [Related]
35. The Combined Use of Fine-Needle Aspiration (FNA) and BRAF V600E Gene Testing: Can it Increase the Definitive Diagnosis Rate of Nodules Categorized as Bethesda III for Papillary Thyroid Carcinoma? Lei L, Hong Qing S, Wei L, Ma Mo Yang F, Xiao Xiang Y. Am Surg; 2024 Dec 25; 90(12):3209-3215. PubMed ID: 39047144 [Abstract] [Full Text] [Related]